dehydroepiandrosterone has been researched along with acyline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amory, JK; Anawalt, BD; Bremner, WJ; Lin, K; Marck, B; Matsumoto, AM; Page, ST; Roth, MY | 1 |
| Amory, JK; Anawalt, BD; Bremner, WJ; Lin, K; Marck, BT; Matsumoto, AM; Nya-Ngatchou, JJ; Page, ST; Roth, MY | 1 |
2 trial(s) available for dehydroepiandrosterone and acyline
| Article | Year |
|---|---|
The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.
Topics: Adolescent; Adult; Androstenedione; Chorionic Gonadotropin; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Gonadotropins; Hormone Antagonists; Humans; Male; Middle Aged; Oligopeptides; Stimulation, Chemical; Testis; Testosterone; Withholding Treatment; Young Adult | 2011 |
Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.
Topics: 14-alpha Demethylase Inhibitors; 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraception; Dehydroepiandrosterone; Drug Design; Drug Synergism; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Middle Aged; Oligopeptides; Placebos; Spermatogenesis; Testis; Testosterone; Young Adult | 2013 |